CompletedNot Applicable

Hair Repigmentation During Cerebrolysin Therapy

Mexico5 participantsStarted 2014-06-02

Plain-language summary

Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes of follicular repigmentation that occurs during the Cerebrolysin treatment.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Known neurologist prescription for Cerebrolysin treatment due ischemic or hemorrhagic stroke, traumatic brain injury or dementia. * Age-related white or gray hair. * Above 40 years old * Voluntarily consents in written informed consent by the principal or legal representative Exclusion Criteria: * Patients with a diagnosis of Chronic Kidney Disease (CKD). * Known history of seizures, epilepsy, or hypersensitivity to one or any drug components. * Pregnant patients. * Patients with a history of recent treatment of hair coloring products.

What they're measuring

Macroscopic evaluation of scalp repigmentation

Timeframe: From the beginning of the treatment until 9th month.

Microscopic evaluation of scalp repigmentation

Timeframe: From the beginning of the treatment until 9th month.

Evaluation of scalp melanocytes function.

Timeframe: From the beginning of the treatment until 9th month.

Trial details

NCT IDNCT05288465

SponsorUniversidad Autonoma de Nuevo Leon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12-07

View on ClinicalTrials.gov More Hair Problems trials